Sermon Charles

Track

Insider profile

Performance

Overall performance
1.8
Performance over holding periods
1.8
30 days 90 days 120 days
Average return -12% 8.2% 15.1%
Success rate 15% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Sermon Charles's trades of Mereo BioPharma Group PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
2.41
Quantity 18,405
Value US$44,356
Transaction date
Purchase
Price
0.54
Quantity 6,355
Value £3,400
Transaction date
Purchase
Price
3.09
Quantity 590
Value US$1,821
Transaction date
Purchase
Price
6.00
Quantity 6,456
Value US$38,736
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-16 2024-09-13
S Sale
8,957 -4.4%
441.53
US$3,254,945 		8,957 -4.4% 441.53 US$3,254,945
2024-09-16 2024-09-12
S Sale
3,855 -33.4%
143.99
US$294,075 		3,855 -33.4% 143.99 US$294,075
2024-09-12 2024-09-12
PrS Proposed sale
99,325
419.47
US$977,153 		99,325 419.47 US$977,153
2024-06-27 2024-06-26
S Sale
32,187 -14.9%
3.39
US$109,217 		32,187 -14.9% 3.39 US$109,217
2024-06-27 2024-06-25
S Sale
14,202 -6.2%
3.69
US$52,461 		14,202 -6.2% 3.69 US$52,461
2024-06-24 2024-06-25
PrS Proposed sale
51,028
3.98
US$203,091 		51,028 3.98 US$203,091
2024-06-20 2024-06-21
PrS Proposed sale
51,028
3.98
US$203,091 		51,028 3.98 US$203,091
2020-10-12 2020-10-09
B Purchase
18,405
2.41
US$44,356 		18,405 2.41 US$44,356
2019-08-16 2019-08-15
B Purchase
6,355
0.54
£3,400 		6,355 0.54 £3,400
2019-08-15 2019-08-14
B Purchase
754
3.11
£2,341 		754 3.11 £2,341
2019-08-15 2019-08-13
B Purchase
590
3.09
US$1,821 		590 3.09 US$1,821
2019-05-01 2019-04-30
B Purchase
6,456
6.00
US$38,736 		6,456 6.00 US$38,736